Edition:
United Kingdom

Coherus BioSciences Inc (CHRS.OQ)

CHRS.OQ on NASDAQ Stock Exchange Global Market

13.94USD
15 Feb 2019
Change (% chg)

$-0.24 (-1.69%)
Prev Close
$14.18
Open
$14.24
Day's High
$14.42
Day's Low
$13.70
Volume
183,872
Avg. Vol
239,596
52-wk High
$20.65
52-wk Low
$8.34

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- December 16 Feb 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 3 3 3 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.60 1.60 1.60 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Dec-19 4 79.43 127.31 50.00 112.87
Earnings (per share)
Year Ending Dec-19 5 -1.27 1.49 -2.20 -1.12

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 0.00 0.00 0.00 0.00
Quarter Ending Jun-18 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 0.00 0.00 0.00 0.00
Quarter Ending Dec-17 3.75 0.00 3.75 100.00
Quarter Ending Sep-17 7.68 0.00 7.68 100.00
Earnings (per share)
Quarter Ending Sep-18 -0.77 -0.87 0.10 -13.52
Quarter Ending Jun-18 -0.64 -0.68 0.04 -5.59
Quarter Ending Mar-18 -0.70 -0.74 0.04 -6.05
Quarter Ending Dec-17 -0.81 -0.84 0.03 -3.09
Quarter Ending Sep-17 -0.81 -1.09 0.28 -33.87

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Dec-19 79.43 79.43 79.43 79.43 112.87
Earnings (per share)
Year Ending Dec-19 -1.27 -1.27 -1.27 -1.27 -1.12

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Dec-19 0 0 0 0
Earnings
Year Ending Dec-19 0 0 0 0